Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

This is a summary. Read the complete story at Yahoo Finance below.

Related Stories

marketsabout 10 hours ago

Winter is coming and energy bills are climbing. ‘Everything just keeps going up.’

Expensive utility bills have become an increasingly sharp thorn for Americans’ wallets, but warmer weather this winter and energy assistance programs can help.

MarketWatch

marketsabout 11 hours ago

Why Nvidia’s stock is dodging the AI credit scare that is crushing Broadcom and Oracle

The P/E ratios have contracted and the CDS spreads have widened in all three cases, but Nvidia appears unscathed

MarketWatch

marketsabout 11 hours ago

‘What you don’t know is greater than anything you do know’: How Ray Dalio would build a portfolio to withstand a popping AI bubble

Look for inflation protection and unappreciated players in artificial intelligence, says the famed hedge-fund founder.

MarketWatch